Pdl Biopharma Inc (PDLI)

R&D Expense Growth

-100.00%

Quarterly · Period ending:

PDLI logo

PDLI R&D Expense Growth

Latest reported-100.00%
PDLI Quarterly R&D Growth (QoQ) (0.00% → -100.00%)
High-resolution chart · PNG

PDLI r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pdl Biopharma Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-100%
-21.0668%
49.3162%
-71.1601%
386.456%
1.9563%
7.8164%
19.9405%
-1.7544%
-13.7453%
8.7791%
20.4959%
-85.8678%
142.4122%
-6.4123%
-2.3797%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-100%
10.6881%
-15.2702%
76.0616%
-51.6082%
-16.5787%
20.604%
-14.9426%
-7.7356%
13.2051%
1.3615%
31.5424%
-5.095%
22.6605%
14.4012%
16.7621%
10.5138%
-14.6303%
-3.0882%
45.0103%
1.2086%
6.8715%
28.4651%
4.3412%
9.8141%
-3.1677%
12.0346%
-4.6562%
10.9765%
2.0972%
-10.7088%
17.7722%
22.9401%
-7.5764%
-7.7062%
-2.9035%
44.3038%
-7.0588%
2.4096%
-6.7416%
0%
21.9178%
14.0625%
-1.5385%
3.1746%
0%
-3.0769%
-2.9851%
-21.1765%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.